These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 11733961

  • 1. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 2. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF.
    Anticancer Res; 2002 Jul 15; 22(2B):1265-71. PubMed ID: 12168936
    [Abstract] [Full Text] [Related]

  • 5. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV, O'Brien TJ.
    J Soc Gynecol Investig; 1997 Jul 15; 4(2):95-102. PubMed ID: 9101469
    [Abstract] [Full Text] [Related]

  • 6. Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.
    Elbendary AA, Cirisano FD, Evans AC, Davis PL, Iglehart JD, Marks JR, Berchuck A.
    Clin Cancer Res; 1996 Sep 15; 2(9):1571-5. PubMed ID: 9816335
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 8. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK.
    Gynecol Oncol; 2001 Dec 15; 83(3):543-8. PubMed ID: 11733969
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J, Sidransky D.
    Oncogene; 1999 Oct 21; 18(43):5843-9. PubMed ID: 10557071
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.
    Kanavaros P, Stefanaki K, Vlachonikolis J, Papalazarou D, Rontogianni D, Arvanitis D, Antonakopoulos G, Gorgoulis V, Bai M, Agnantis NJ.
    Anticancer Res; 2000 Oct 21; 20(6B):4619-25. PubMed ID: 11205312
    [Abstract] [Full Text] [Related]

  • 11. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
    Bai M, Vlachonikolis J, Agnantis NJ, Tsanou E, Dimou S, Nicolaides C, Stefanaki S, Pavlidis N, Kanavaros P.
    Mod Pathol; 2001 Nov 21; 14(11):1105-13. PubMed ID: 11706071
    [Abstract] [Full Text] [Related]

  • 12. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A, Oda Y, Kurihara S, Ohishi Y, Yasunaga M, Nishimura I, Takagi E, Kobayashi H, Wake N, Tsuneyoshi M.
    Pathol Int; 2008 Dec 21; 58(12):757-64. PubMed ID: 19067849
    [Abstract] [Full Text] [Related]

  • 13. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 14. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA.
    Cancer Res; 2000 Jul 15; 60(14):3862-71. PubMed ID: 10919661
    [Abstract] [Full Text] [Related]

  • 15. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H.
    Oncogene; 1997 Oct 15; 15(18):2225-32. PubMed ID: 9393981
    [Abstract] [Full Text] [Related]

  • 16. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD.
    Clin Cancer Res; 1999 Apr 15; 5(4):791-800. PubMed ID: 10213214
    [Abstract] [Full Text] [Related]

  • 17. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y, Yamamoto H, Takahira T, Kobayashi C, Kawaguchi K, Tateishi N, Nozuka Y, Tamiya S, Tanaka K, Matsuda S, Yokoyama R, Iwamoto Y, Tsuneyoshi M.
    J Pathol; 2005 Dec 15; 207(4):410-21. PubMed ID: 16177957
    [Abstract] [Full Text] [Related]

  • 18. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.
    Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T, Terada M.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):1090-5. PubMed ID: 8093026
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 15; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
    Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG.
    Cancer Res; 1997 Aug 01; 57(15):3126-30. PubMed ID: 9242437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.